Abiomed Inc.

NASDAQ: ABMD · Real-Time Price · USD
381.02
0.00 (0.00%)
At close: Dec 21, 2022, 10:00 PM

Abiomed Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2022 FY 2021
Period Ending Mar 31, 2022 Mar 31, 2021
Revenue
1.03B 847.52M
Cost of Revenue
188.16M 161.91M
Gross Profit
843.6M 685.62M
Operating Income
372.69M 229.56M
Interest Income
49.84M n/a
Pretax Income
190.56M 288.22M
Net Income
136.5M 225.53M
Selling & General & Admin
423.49M 334.18M
Research & Development
163.4M 121.88M
Other Expenses
n/a n/a
Operating Expenses
586.89M 456.06M
Interest Expense
49.84M n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
775.05M 617.97M
Income Tax Expense
54.05M 62.7M
Shares Outstanding (Basic)
45.45M 45.14M
Shares Outstanding (Diluted)
45.88M 45.67M
EPS (Basic)
3.00 5.00
EPS (Diluted)
2.98 4.94
EBITDA
400.78M 246.94M
EBIT
472.37M n/a
Depreciation & Amortization
28.09M 24.1M